FluLaval Quadrivalent FDA Approval History
Last updated by Judith Stewart, BPharm on Oct 28, 2020.
FluLaval Quadrivalent is an inactivated influenza virus vaccine indicated for active immunization against influenza disease in people aged 6 months and older.
Development Timeline for FluLaval Quadrivalent
|Nov 18, 2016||Approval GSK Receives FDA Approval for Expanded Indication for FluLaval Quadrivalent (Influenza Vaccine) for Infants 6 Months and Older|
|Aug 16, 2013||Approval FDA Approves FluLaval Quadrivalent|
|Oct 5, 2006||Approval FDA Approves FluLaval for Upcoming Influenza Season|
|Mar 23, 2006||GlaxoSmithKline Submits Biologics License Application for FDA Approval of FluLaval|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.